• Ergonomic intervention: its effect on working posture and musculoskeletal symptoms in female biomedical scientists.

      Kilroy, N; Dockrell, S; Physiotherapy Department, Tullamore General Hospital, Co. Offaly, Ireland. (2000)
      This study investigates the effect of ergonomic intervention on working posture and musculoskeletal symptoms in female biomedical scientists. The Nordic musculoskeletal questionnaire (NMQ), body discomfort chart (BDC) and rapid upper-limb assessment (RULA) are the tools for assessment. The study was conducted in three phases: pre-intervention, intervention and post-intervention. Pre-intervention, 79% of subjects reported a three-month prevalence of symptoms, and these were reported more frequently by those working in haematology/transfusion. Analysis by RULA showed that the majority (59%) of postures had a grand score of four. A further 24% had scores of five or six. The highest frequency of poor postures was seen in haematology/transfusion. Intervention comprised physical workplace changes, a seminar, and advice on risk factors. In the post-intervention phase, baseline measurements were repeated. Reporting of three-month prevalence of symptoms had decreased to 54%, and reports of body discomfort also had decreased. The majority (64%) had a RULA grand score of three. No observed postures had scores of five or six. In conclusion, ergonomic intervention resulted in an improvement in working postures, and a decrease in the prevalence of musculoskeletal symptoms and body discomfort. Analysis of findings indicate that RULA scores generally corresponded with reporting of symptoms (NMQ) and discomfort (BDC).
    • Patients' lived experience of myeloma.

      Kelly, Mary; Dowling, Maura; Regional Oncology Haematology Day Unit, Tullamore General Hospital, Ireland. Maura.dowling@nuigalway.ie (2011-03)
      To explore patients' lived experience of being diagnosed with myeloma.
    • Review of a single contemporary femoral neck fracture fixation method in young patients.

      Henari, Shwan; Leonard, Michael; Hamadto, Mohammed; Cogley, David; Department of Orthopedics, Midlands Regional Hospital, Tullamore, Ireland. shwanhenari@hotmail.com (2011-03)
      An intracapsular femoral neck fracture in a young patient is a rare and difficult injury to manage. The occurrence of complications following fixation is multifactorial. Initial displacement and timing and accuracy of reduction are the key factors affecting outcome. The severities of the trauma to the hip and the impact of the intracapsular hematoma also play a role, the importance of which remains poorly understood. The purpose of this study was to evaluate the high incidence of femoral neck fractures treated in our institution over a 7-month period, to record the long-term outcome of these patients, all of whom were treated with contemporary methods of internal fixation, and to highlight the reasons for this injury being termed an "orthopedic emergency" and its differences from the same injury in the elderly population. We performed a retrospective analysis of 12 cases of intracapsular femur neck fracture in patients younger than 50 years treated over 7 months in a regional trauma center. All patients underwent satisfactory reduction and fixation. Nine of the 12 patients had a good outcome at a mean follow-up of 29 months. One patient developed a nonunion of the femoral head requiring total hip arthroplasty, one developed avascular necrosis of the femoral head, and one developed partial avascular necrosis. This compares favorably with other studies.
    • Through the looking glass; bioactive glass S53P4 (BonAlive®) in the treatment of chronic osteomyelitis.

      McAndrew, J; Efrimescu, C; Sheehan, E; Niall, D; Department of Orthopaedic Surgery, Midland Regional Hospital, Tullamore, County Offaly, Ireland. josephmcandrew@gmail.com (2013-09)
      In terms of eradication, osteomyelitis represents one of the most challenging infective conditions in medicine and surgery. In recent years, the use of bioactive glass in conjunction with antimicrobial therapy has emerged as a viable new treatment.
    • Young patients with chronic lymphocytic leukaemia.

      Kelly, Mary; Dowling, Maura; Meenaghan, Teresa; Tullamore General Hospital, Offaly, Ireland. (2012-01-31)